Losortan Potassium Tablet, Film Coated
Product Images NDC 63187-072

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losortan Potassium (NDC 63187-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-072-30 (Losartan Potassium 100mg)

Label for Losartan Potassium 100 mg film-coated tablets from Proficient Rx LP. The label states #30 tablets per package, mentions the tablets are white to off-white, capsule-shaped, and debossed with the logo "Z18" on one side. It includes manufacturer information (Cadila Healthcare Ltd., India) and storage instructions (20°-25°C). Multiple smaller labels repeat the product name, strength, quantity, lot number, and expiration date placeholders.*

FDA Label Image

Structured Formula For Losartan (Losartanpotasiumtabs Figure 01)

Chemical structure of Losartan Potassium, representing its molecular composition including a chlorinated imidazole ring, biphenyl group, and potassium ion.*

FDA Label Image

Structured Formula For Losartan (Losartanpotasiumtabs Figure 02)

A line graph comparing the percentage of patients with a primary endpoint over 66 study months for Atenolol (dashed line) and Losartan Potassium (solid line). The graph shows a lower percentage for Losartan Potassium. Annotations include an adjusted risk reduction of 13% with a p-value of 0.021.*

FDA Label Image

Structured Formula For Losartan (Losartanpotasiumtabs Figure 03)

A line graph comparing the percentage of patients with fatal/non-fatal stroke over 66 months between two treatments, Atenolol and Losartan Potassium. The graph shows cumulative percentages on the y-axis and study months on the x-axis, indicating lower stroke rates with Losartan Potassium compared to Atenolol. An adjusted risk reduction of 25% with a p-value of 0.001 is noted.*

FDA Label Image

Structured Formula For Losartan (Losartanpotasiumtabs Figure 04)

A forest plot comparing Losartan-K and Atenolol in terms of primary composite and stroke (fatal/non-fatal) hazard ratios across various subgroups. Subgroups include overall results, age, gender, race, ISH status, diabetes, and history of cardiovascular disease (CVD). The plot shows event rates (%) and hazard ratios with 95% confidence intervals, indicating relative favorability between Losartan-K and Atenolol.*

FDA Label Image

Structure Product Formula For Losartan (Losartanpotasiumtabs Figure 05)

A line graph comparing the percentage of patients with an event over 48 months for Losartan Potassium Tablet versus placebo. The graph shows a lower percentage for Losartan Potassium compared to placebo, with a reported risk reduction of 16.1% and a p-value of 0.022 indicating statistical significance.*

FDA Label Image

63187-071-30 (Losartanpotasiumtabs Figure 06)

Losartan Potassium 50 mg tablets label from Proficient Rx LP. The label states the tablets are film-coated, capsule-shaped, white to off-white with debossed "Z16" logo on one side. Bottle contains 30 tablets. Manufactured by Cadila Healthcare Ltd., India, with storage instructions at 20°-25°C (68°-77°F). Includes NDC 63187-071-30 and packaging details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.